*Core Facilities, West China Hospital, Sichuan University, Chengdu, People's Republic of China;
†Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China; and
‡Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, People's Republic of China.
Correspondence: Xiao-Xiao Wang, PhD, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, People's Republic of China (e-mail: [email protected]).
Supported by Chongqing Research Institute Performance Incentive Guidance Special Project (cstc2019jxjl130018), the National Natural Science Foundation of China (81700229), and Scientific research topic of Sichuan Provincial Health and Health Commission (20ZD004). The construction project of the key specialty of Chongqing clinical pharmacy.
The authors report no conflicts of interest.
Y. -J. Zhang and S.-S. Wu contributed equally to this work.